Skip to main content
Top
Published in: Clinical Rheumatology 10/2016

01-10-2016 | Original Article

Intracardiac thrombus in patients with Behcet’s disease: clinical correlates, imaging features, and outcome: a retrospective, single-center experience

Authors: Hui Wang, Xiaoxiao Guo, Zhuang Tian, Yongtai Liu, Qian Wang, Mengtao Li, Xiaofeng Zeng, Quan Fang

Published in: Clinical Rheumatology | Issue 10/2016

Login to get access

Abstract

Intracardiac thrombus (ICT) is a rare but serious complication of Behcet’s disease (BD). The study was to report the clinical characteristics, imaging features, treatment, and outcomes of BD patients with ICT in a single tertiary center. A series of 626 BD patients admitted to Peking Union Medical College hospital between April 2003 and April 2013 were reviewed. A total of 12 (1.9 %) BD patients with ICT were included. ICT was presenting manifestation of BD in 5 of the 12 patients (41.7 %) and occurred mostly in men (9/12, 75 %) younger than 40 years. Patients with ICT had more arterial (66.7 vs. 7.3 %, p < 0.001) and venous involvement (75.0 vs. 8.1 %, p < 0.001) compared to those without ICT. Right heart was the most frequent site of ICT (11/12, 91.7 %). Thrombus were hyperechogenic and immobile with a broad-based attachment on echocardiography in most cases (11/12, 91.7 %). Cardiac magnetic resonance (CMR) was performed in four patients. All thrombi showed isointense on T1-weighted image, while all but one were hypointense on T2-weighted image without delayed enhancement. Remission of ICT was associated with therapy of anticoagulant, corticosteroid, and immunosuppressant in most cases (10/12, 83.3 %). There was no death, and relapses of ICT occurred in only one patient after tapering of immunosuppressant during follow-up. A diagnosis of BD should be considered when a young male patient presents with a mass in the right-sided heart accompanied by vascular lesions. Medical therapy especially adequate immunosuppressants might be the first choice for BD patients with ICT.
Literature
1.
2.
go back to reference Koc Y, Gullu I, Akpek G et al (1992) Vascular involvement in Behcet’s disease. J Rheumatol 19:402–410PubMed Koc Y, Gullu I, Akpek G et al (1992) Vascular involvement in Behcet’s disease. J Rheumatol 19:402–410PubMed
3.
go back to reference Geri G, Wechsler B, Du Thi Huong L et al (2012) Spectrum of cardiac lesions in Behcet disease: a series of 52 patients and review of the literature. Medicine (Baltimore) 91:25–34CrossRef Geri G, Wechsler B, Du Thi Huong L et al (2012) Spectrum of cardiac lesions in Behcet disease: a series of 52 patients and review of the literature. Medicine (Baltimore) 91:25–34CrossRef
4.
go back to reference Davies JD (1973) Behcet’s syndrome with haemoptysis and pulmonary lesions. J Pathol 109:351–356CrossRefPubMed Davies JD (1973) Behcet’s syndrome with haemoptysis and pulmonary lesions. J Pathol 109:351–356CrossRefPubMed
5.
go back to reference Kajiya T, Anan R, Kameko M et al (2007) Intracardiac thrombus, superior vena cava syndrome, and pulmonary embolism in a patient with Behcet’s disease: a case report and literature review. Heart Vessels 22:278–283CrossRefPubMed Kajiya T, Anan R, Kameko M et al (2007) Intracardiac thrombus, superior vena cava syndrome, and pulmonary embolism in a patient with Behcet’s disease: a case report and literature review. Heart Vessels 22:278–283CrossRefPubMed
6.
go back to reference Zhu YL, Wu QJ, Guo LL et al (2012) The clinical characteristics and outcome of intracardiac thrombus and aortic valvular involvement in Behcet’s disease: an analysis of 20 cases. Clin Exp Rheumatol 30:S40–S45PubMed Zhu YL, Wu QJ, Guo LL et al (2012) The clinical characteristics and outcome of intracardiac thrombus and aortic valvular involvement in Behcet’s disease: an analysis of 20 cases. Clin Exp Rheumatol 30:S40–S45PubMed
7.
go back to reference Khammar Z, Berrady R, Boukhrissa A et al (2011) Intracardiac thrombosis in Behcet disease: clinical presentation and outcome of three cases. J Mal Vasc 36:270–273CrossRefPubMed Khammar Z, Berrady R, Boukhrissa A et al (2011) Intracardiac thrombosis in Behcet disease: clinical presentation and outcome of three cases. J Mal Vasc 36:270–273CrossRefPubMed
8.
go back to reference Hammami R, Abid L, Frikha F et al (2012) Intracardiac thrombus in a young man: don’t forget Behcet’s disease! Intern Med 51:1865–1867CrossRefPubMed Hammami R, Abid L, Frikha F et al (2012) Intracardiac thrombus in a young man: don’t forget Behcet’s disease! Intern Med 51:1865–1867CrossRefPubMed
9.
go back to reference Emmungil H, Yasar Bilge NS, Kucuksahin O et al (2014) A rare but serious manifestation of Behcet’s disease: intracardiac thrombus in 22 patients. Clin Exp Rheumatol 32:S87–S92PubMed Emmungil H, Yasar Bilge NS, Kucuksahin O et al (2014) A rare but serious manifestation of Behcet’s disease: intracardiac thrombus in 22 patients. Clin Exp Rheumatol 32:S87–S92PubMed
10.
go back to reference International Study Group for Behcet’s Disease (1990) Criteria for diagnosis of Behcet’s disease. International Study Group for Behcet’s Disease. Lancet 335:1078–1080 International Study Group for Behcet’s Disease (1990) Criteria for diagnosis of Behcet’s disease. International Study Group for Behcet’s Disease. Lancet 335:1078–1080
11.
go back to reference International Team for the Revision of the International Criteria for Behcet’s Disease (2006) Revision of the International Criteria for Behcet’s Disease (ICBD). Clin Exp Rheumatol 24:S14–S15 International Team for the Revision of the International Criteria for Behcet’s Disease (2006) Revision of the International Criteria for Behcet’s Disease (ICBD). Clin Exp Rheumatol 24:S14–S15
12.
go back to reference International Team for the Revision of the International Criteria for Behcet’s D (2014) The International Criteria for Behcet’s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol 28:338–347CrossRef International Team for the Revision of the International Criteria for Behcet’s D (2014) The International Criteria for Behcet’s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol 28:338–347CrossRef
13.
14.
go back to reference Mogulkoc N, Burgess MI, Bishop PW (2000) Intracardiac thrombus in Behcet’s disease: a systematic review. Chest 118:479–487CrossRefPubMed Mogulkoc N, Burgess MI, Bishop PW (2000) Intracardiac thrombus in Behcet’s disease: a systematic review. Chest 118:479–487CrossRefPubMed
16.
go back to reference Wang LY, Zhao DB, Gu J et al (2010) Clinical characteristics of Behcet’s disease in China. Rheumatol Int 30:1191–1196CrossRefPubMed Wang LY, Zhao DB, Gu J et al (2010) Clinical characteristics of Behcet’s disease in China. Rheumatol Int 30:1191–1196CrossRefPubMed
17.
go back to reference Aksu T, Tufekcioglu O (2015) Intracardiac thrombus in Behcet’s disease: four new cases and a comprehensive literature review. Rheumatol Int 35:1269–1279CrossRefPubMed Aksu T, Tufekcioglu O (2015) Intracardiac thrombus in Behcet’s disease: four new cases and a comprehensive literature review. Rheumatol Int 35:1269–1279CrossRefPubMed
18.
go back to reference Atzeni F, Sarzi-Puttini P, Doria A et al (2005) Behçet’s disease and cardiovascular involvement. Lupus 14:723–726CrossRefPubMed Atzeni F, Sarzi-Puttini P, Doria A et al (2005) Behçet’s disease and cardiovascular involvement. Lupus 14:723–726CrossRefPubMed
19.
go back to reference Calamia KT, Schirmer M, Melikoglu M (2011) Major vessel involvement in Behcet’s disease: an update. Curr Opin Rheumatol 23:24–31CrossRefPubMed Calamia KT, Schirmer M, Melikoglu M (2011) Major vessel involvement in Behcet’s disease: an update. Curr Opin Rheumatol 23:24–31CrossRefPubMed
20.
go back to reference Fernandez-Bello I, Lopez-Longo FJ, Arias-Salgado EG et al (2013) Behcet’s disease: new insight into the relationship between procoagulant state, endothelial activation/damage and disease activity. Orphanet J Rare Dis 8:81CrossRefPubMedPubMedCentral Fernandez-Bello I, Lopez-Longo FJ, Arias-Salgado EG et al (2013) Behcet’s disease: new insight into the relationship between procoagulant state, endothelial activation/damage and disease activity. Orphanet J Rare Dis 8:81CrossRefPubMedPubMedCentral
21.
go back to reference Direskeneli H, Keser G, D’cruz D et al (1995) Anti-endothelial cell antibodies, endothelial proliferation and von Willebrand factor antigen in Behcet’s disease. Clin Rheumatol 14:55–61CrossRefPubMed Direskeneli H, Keser G, D’cruz D et al (1995) Anti-endothelial cell antibodies, endothelial proliferation and von Willebrand factor antigen in Behcet’s disease. Clin Rheumatol 14:55–61CrossRefPubMed
22.
go back to reference Kiraz S, Ertenli I, Ozturk MA et al (2002) Pathological haemostasis and “prothrombotic state” in Behcet’s disease. Thromb Res 105:125–133CrossRefPubMed Kiraz S, Ertenli I, Ozturk MA et al (2002) Pathological haemostasis and “prothrombotic state” in Behcet’s disease. Thromb Res 105:125–133CrossRefPubMed
23.
go back to reference Louali FE, Tamdy A, Soufiani A et al (2010) Cardiac thrombosis as a manifestation of Behcet syndrome. Tex Heart Inst J 37:568–571PubMedPubMedCentral Louali FE, Tamdy A, Soufiani A et al (2010) Cardiac thrombosis as a manifestation of Behcet syndrome. Tex Heart Inst J 37:568–571PubMedPubMedCentral
24.
go back to reference Mollet NR, Dymarkowski S, Volders W et al (2002) Visualization of ventricular thrombi with contrast-enhanced magnetic resonance imaging in patients with ischemic heart disease. Circulation 106:2873–2876CrossRefPubMed Mollet NR, Dymarkowski S, Volders W et al (2002) Visualization of ventricular thrombi with contrast-enhanced magnetic resonance imaging in patients with ischemic heart disease. Circulation 106:2873–2876CrossRefPubMed
25.
go back to reference Srichai MB, Junor C, Rodriguez LL et al (2006) Clinical, imaging, and pathological characteristics of left ventricular thrombus: a comparison of contrast-enhanced magnetic resonance imaging, transthoracic echocardiography, and transesophageal echocardiography with surgical or pathological validation. Am Heart J 152:75–84CrossRefPubMed Srichai MB, Junor C, Rodriguez LL et al (2006) Clinical, imaging, and pathological characteristics of left ventricular thrombus: a comparison of contrast-enhanced magnetic resonance imaging, transthoracic echocardiography, and transesophageal echocardiography with surgical or pathological validation. Am Heart J 152:75–84CrossRefPubMed
26.
go back to reference Ahn JK, Lee YS, Jeon CH et al (2008) Treatment of venous thrombosis associated with Behcet’s disease: immunosuppressive therapy alone versus immunosuppressive therapy plus anticoagulation. Clin Rheumatol 27:201–205CrossRefPubMed Ahn JK, Lee YS, Jeon CH et al (2008) Treatment of venous thrombosis associated with Behcet’s disease: immunosuppressive therapy alone versus immunosuppressive therapy plus anticoagulation. Clin Rheumatol 27:201–205CrossRefPubMed
27.
go back to reference Desbois AC, Wechsler B, Resche-Rigon M et al (2012) Immunosuppressants reduce venous thrombosis relapse in Behcet’s disease. Arthritis Rheum 64:2753–2760CrossRefPubMed Desbois AC, Wechsler B, Resche-Rigon M et al (2012) Immunosuppressants reduce venous thrombosis relapse in Behcet’s disease. Arthritis Rheum 64:2753–2760CrossRefPubMed
29.
go back to reference Owlia MB, Mehrpoor G (2012) Behcet’s disease: new concepts in cardiovascular involvements and future direction for treatment. ISRN Pharmacol 2012:760484PubMedPubMedCentral Owlia MB, Mehrpoor G (2012) Behcet’s disease: new concepts in cardiovascular involvements and future direction for treatment. ISRN Pharmacol 2012:760484PubMedPubMedCentral
Metadata
Title
Intracardiac thrombus in patients with Behcet’s disease: clinical correlates, imaging features, and outcome: a retrospective, single-center experience
Authors
Hui Wang
Xiaoxiao Guo
Zhuang Tian
Yongtai Liu
Qian Wang
Mengtao Li
Xiaofeng Zeng
Quan Fang
Publication date
01-10-2016
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 10/2016
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-015-3161-1

Other articles of this Issue 10/2016

Clinical Rheumatology 10/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.